MyAverix Finance
US · Healthcare
Lakefront Biotherapeutics NV (LKFT)
Biotechnology
Lakefront Biotherapeutics NV (LKFT) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-19, reported market cap is $1.78B, P/E ratio is 3.12, net margin is 46.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for LKFT
Lakefront Biotherapeutics NV (LKFT) — FAQ
What is Lakefront Biotherapeutics NV's market cap?
Lakefront Biotherapeutics NV (LKFT) has a reported market cap of $1.78B (data as of 2026-05-19).
What is LKFT's P/E ratio?
The price-to-earnings (P/E) ratio for Lakefront Biotherapeutics NV (LKFT) is 3.12 (data as of 2026-05-19).
Does Lakefront Biotherapeutics NV pay a dividend?
Dividend yield is not available in the current snapshot for Lakefront Biotherapeutics NV (LKFT). Check the MyAverix Finance app for the latest dividend data.
What sector is Lakefront Biotherapeutics NV in?
Lakefront Biotherapeutics NV (LKFT) is classified in the Healthcare sector (Biotechnology industry).
What exchange is LKFT listed on?
LKFT is listed on US.
What is Lakefront Biotherapeutics NV's net margin?
Lakefront Biotherapeutics NV (LKFT) reports a net margin of 46.8% (data as of 2026-05-19).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.